Bedel Financial Consulting, Inc. Eli Lilly & CO Transaction History

Bedel Financial Consulting, Inc.

$645 Million
Q1 2024

A detailed history of Bedel Financial Consulting, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Bedel Financial Consulting, Inc. holds 15,200 shares of LLY stock, worth $13.8 Million. This represents 1.83% of its overall portfolio holdings.

Number of Shares

15,200

Previous 15,200 -0.0%

Holding current value

$13.8 Million

Previous $8.86 Million 33.45%

% of portfolio

1.83%

Previous 1.61%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$592.2 - $792.28 $185,950 - $248,775	-314 Reduced 0.1%	330,199 $257 Million
Q4 2023 Feb 08, 2024	BUY	$525.19 - $619.13 $2.61 Million - $3.08 Million	4,972 Added 1.53%	330,513 $193 Million
Q3 2023 Feb 08, 2024	BUY	$434.7 - $599.3 $1.47 Million - $2.02 Million	3,376 Added 1.05%	325,541 $175 Million
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $97,856 - $130,845	-279 Reduced 0.09%	322,165 $151 Million
Q1 2023 May 02, 2023	SELL	$310.63 - $364.82 $176,437 - $207,217	-568 Reduced 0.18%	322,444 $111 Million

Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $126,690 - $147,619	-394 Reduced 0.12%	323,012 $118 Million
Q3 2022 Nov 08, 2022	SELL	$296.48 - $337.87 $2.65 Million - $3.02 Million	-8,933 Reduced 2.69%	323,406 $118 Million
Q2 2022 Aug 04, 2022	BUY	$278.73 - $327.27 $67,452 - $79,199	242 Added 0.07%	332,339 $108 Million
Q1 2022 Apr 19, 2022	BUY	$234.69 - $291.66 $138,467 - $172,079	590 Added 0.18%	332,097 $95.1 Million
Q4 2021 Jan 11, 2022	SELL	$224.85 - $279.04 $395,736 - $491,110	-1,760 Reduced 0.53%	331,507 $91.6 Million
Q3 2021 Oct 12, 2021	BUY	$221.6 - $272.71 $576,824 - $709,864	2,603 Added 0.79%	333,267 $77 Million
Q2 2021 Aug 03, 2021	BUY	$180.55 - $233.54 $142,995 - $184,963	792 Added 0.24%	330,664 $75.9 Million
Q1 2021 Apr 26, 2021	SELL	$164.32 - $212.72 $167,113 - $216,336	-1,017 Reduced 0.31%	329,872 $61.6 Million
Q4 2020 Feb 02, 2021	SELL	$130.46 - $172.63 $476,179 - $630,099	-3,650 Reduced 1.09%	330,889 $55.9 Million
Q3 2020 Oct 20, 2020	SELL	$146.22 - $169.13 $27,928 - $32,303	-191 Reduced 0.06%	334,539 $49.5 Million
Q2 2020 Jul 14, 2020	SELL	$136.42 - $164.18 $228,503 - $275,001	-1,675 Reduced 0.5%	334,730 $55 Million
Q1 2020 May 06, 2020	SELL	$119.05 - $147.35 $2.2 Million - $2.72 Million	-18,465 Reduced 5.2%	336,405 $46.7 Million
Q4 2019 Jan 28, 2020	SELL	$106.92 - $132.43 $263,878 - $326,837	-2,468 Reduced 0.69%	354,870 $46.6 Million
Q3 2019 Oct 09, 2019	BUY	$106.79 - $116.16 $11,853 - $12,893	111 Added 0.03%	357,338 $40 Million
Q2 2019 Aug 01, 2019	BUY	$110.79 - $129.32 $91,069 - $106,301	822 Added 0.23%	357,227 $39.6 Million
Q1 2019 May 02, 2019	SELL	$111.31 - $131.02 $354,299 - $417,036	-3,183 Reduced 0.89%	356,405 $46.2 Million
Q4 2018 Jan 28, 2019	SELL	$105.9 - $118.64 $171,981 - $192,671	-1,624 Reduced 0.45%	359,588 $41.6 Million
Q3 2018 Nov 01, 2018	SELL	$85.86 - $107.31 $416,421 - $520,453	-4,850 Reduced 1.32%	361,212 $40.1 Million
Q2 2018 Jul 18, 2018	BUY	$75.7 - $86.88 $164,874 - $189,224	2,178 Added 0.6%	366,062 $31.2 Million
Q1 2018 May 03, 2018	BUY	$74.21 - $87.6 $1.21 Million - $1.42 Million	16,239 Added 4.67%	363,884 $28.2 Million
Q4 2017 Feb 06, 2018	BUY	$81.94 - $87.89 $28.5 Million - $30.6 Million	347,645	347,645 $29.4 Million

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.

Account

Bedel Financial Consulting, Inc. Eli Lilly & CO Transaction History